A preliminary exploration of a predictive model and nomogram for the efficacy of compound digestive enzyme therapy based on serum (PGI, PGII, VIP, and PRDX1) in patients with functional dyspepsia
The therapeutic effect prediction model of compound digestive enzyme base on serum PGI, PGII, VIP, PRDX1 in patients with FD has some clinical value, but it still need to be further verified by large sample size and multi-center study.
Authors
- Wenqiang Ren
- Jianji Pan (ORCID: https://orcid.org/0000-0002-3211-7874)
- Bo Zhang (ORCID: https://orcid.org/0000-0002-6571-5213)
Institutions
- Fourth People’s Hospital of Jinan (CN)
- Second Hospital of Shandong University (CN)
- Jinan Central Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1186/s12876-025-04024-5
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00